By VGMG Staff
March 30, 2026
In a landmark decision reshaping the landscape of elite women’s sports, the International Olympic Committee (IOC) has confirmed that beginning with the 2028 Los Angeles Games, participation in women’s Olympic events will be restricted to athletes classified as biological females, verified through a one-time SRY gene screening protocol.
The policy, ratified by the IOC Executive Board after an 18-month global consultation process, marks the most definitive stance the organization has taken on gender eligibility in Olympic competition. Under the new framework, all athletes seeking to compete in women’s categories at the Olympics, Youth Olympics, or official qualifying events must undergo genetic testing to confirm the absence of the SRY gene—a DNA segment typically found on the Y chromosome that initiates male sexual development during embryogenesis.
🔬 How the Verification Process Works
According to IOC documentation, the SRY screening can be conducted via saliva swab, oral sample, or blood test. Athletes who test negative for the gene will receive permanent eligibility for women’s events, with retesting required only in cases of documented procedural error or medical anomaly. Those who test positive will generally be ineligible for women’s competition, though limited exceptions may apply for specific intersex variations such as Complete Androgen Insensitivity Syndrome (CAIS), subject to independent medical review.
“Fairness and safety are non-negotiable pillars of Olympic sport,” said IOC President Kirsty Coventry during a virtual press briefing. “While we deeply respect every athlete’s identity and journey, the integrity of women’s competition must be protected. At the elite level, even marginal physiological advantages can determine podium placement—and that matters.”
🌍 A Global Consultation, Divided Responses
The policy development process included input from more than 1,100 athletes across six continents, alongside consultations with medical experts, ethicists, legal scholars, and international federations. Yet the announcement has triggered sharply contrasting reactions worldwide.
Supporters argue the move restores competitive equity. World Athletics, which implemented similar restrictions in 2023, welcomed the decision: “Women and girls deserve a level playing field. Biology matters in sport, and this policy affirms that principle with scientific rigor.”
Critics, however, raise concerns about privacy, ethics, and inclusion. South African middle-distance champion Caster Semenya, herself a athlete with differences of sex development (DSD), stated: “If the IOC truly listened to athletes, this policy would not exist. It smells less of science and more of stigma.” LGBTQ+ advocacy groups, including Stonewall, warned the measure could marginalize vulnerable athletes and send a chilling message to transgender and intersex youth in grassroots sports.
France’s Sports Ministry has already signaled potential legal challenges, noting that mandatory genetic testing may conflict with national bioethics laws and data protection statutes.
⚖️ Navigating Science, Ethics, and Sport
The IOC emphasizes that the policy is not retroactive and does not apply to community, recreational, or national-level competitions. Athletes affected will receive access to confidential counseling, medical guidance, and appeals processes. Privacy safeguards—including secure data handling and limited access to test results—are embedded in the implementation protocol.
Dr. Jane Thornton, the IOC’s Director of Health, Medicine, and Science, underscored the organization’s dual commitment: “We are guided by the best available evidence, but also by empathy. Every athlete deserves dignity, respect, and a clear pathway to compete.”
🗓️ What Happens Next?
With the Los Angeles Olympics still over two years away, international federations now have a window to align their own eligibility rules with the IOC framework. The organization has committed to ongoing review, with a formal evaluation scheduled for 2027 to assess implementation challenges, scientific developments, and athlete feedback.
For now, the decision places the Olympic Movement at the center of a global conversation—one that extends far beyond sport, touching on identity, equity, human rights, and the evolving definition of fairness in competition.
As Coventry concluded: “This is not about exclusion. It is about ensuring that every woman who steps onto an Olympic stage does so with confidence that the contest is just. That is a promise we owe to every girl who dreams of gold.”
As an opponent of this policy, I must clearly state that using SRY gene screening as a “one-time, permanent” criterion for eligibility in women’s events is scientifically indefensible and ethically deeply troubling.
First, science has long proven that biological sex is not a simple XX/XY binary. The presence of the SRY gene, while a key initiator of male development, does not automatically translate into the same physiological advantages as a typical male. For example, individuals with Complete Androgen Insensitivity Syndrome (CAIS) possess the SRY gene, yet due to androgen receptor dysfunction, they develop typical female external genitalia and show no significant differences in athletic performance metrics (such as muscle mass or hemoglobin levels) compared to non-DSD females. Although the policy claims case-by-case review for exceptions like CAIS, in practice these athletes often undergo humiliating and protracted “medical verification,” which is essentially exclusion by genetic proxy.
Second, mandatory genetic screening revives the infamous history of “gender verification” in sports. From nude parades in the 1960s to chromosome testing in the 1990s, such practices have wrongly excluded many elite female athletes and caused lifelong psychological trauma. Repackaging similar methods under the banner of “fairness” simply dresses outdated biological determinism in modern technical clothing. History has shown that any attempt to define “woman” through a single biological marker ultimately harms those who least fit stereotypical expectations of femaleness.
Third, this policy is particularly draconian toward transgender athletes. Many trans women undergo hormone therapy before or during early puberty, resulting in physical development nearly indistinguishable from that of cisgender women. A single SRY-positive test result permanently excludes them, without any consideration of more relevant indicators such as hormone levels or muscle loss. The IOC itself acknowledged in 2021 that sex is not binary and that testosterone is not the sole determinant of athletic advantage. Retreating to a cruder genetic screen is deeply perplexing.
Fourth, privacy and human rights violations cannot be dismissed lightly. Forcing elite female athletes worldwide to provide DNA samples and submit to scrutiny over whether they carry a “male gene” is a grave infringement on bodily autonomy. Even with claimed data protection measures, once samples are collected, risks of leakage, misuse, or repurposing for other purposes remain. It is no coincidence that countries like France have pointed out conflicts with bioethics laws.
Finally, the chilling effect of this policy on grassroots sports is extremely dangerous. It sends a message to society: if you do not look like a “typical” female, or if your gender identity does not conform to binary expectations, you have no place in sports. This will discourage countless young people from participating and exacerbate existing discrimination and bullying.
True fairness should not be built on exclusion and humiliation. We need flexible rules based on individual athletic capability, not a retreat into the dark ages of genetic determinism. The IOC claims this is “not about exclusion,” but that is exactly what it is – exclusion of those with atypical genes, different identities, or simply those who do not fit others’ expectations of womanhood. This betrays the fundamental Olympic promise of “sport for all.”